-+ 0.00%
-+ 0.00%
-+ 0.00%

SYNDAX PHARMACEUTICALS, INC. : UBS CUTS TARGET PRICE TO $33 FROM $37

Reuters·08/21/2026 12:13:17

Please log in to view news